Polycystic ovary syndrome in adolescence.
暂无分享,去创建一个
[1] Julie Brown,et al. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. , 2009, The Cochrane database of systematic reviews.
[2] R. Klein,et al. Role of brain insulin receptor in control of body weight and reproduction. , 2006, Science.
[3] E. Baracat,et al. Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome. , 2004, The Journal of clinical endocrinology and metabolism.
[4] M. Quinkler,et al. Androgen generation in adipose tissue in women with simple obesity--a site-specific role for 17beta-hydroxysteroid dehydrogenase type 5. , 2004, The Journal of endocrinology.
[5] P. Pyett,et al. Oestrogen treatment to reduce the adult height of tall girls: long-term effects on fertility , 2004, The Lancet.
[6] D. Jakubowicz,et al. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity. , 2004, Fertility and sterility.
[7] D. Ehrmann. Polycystic ovary syndrome. , 2004, The New England journal of medicine.
[8] W. Crowley,et al. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. , 2004, The Journal of clinical endocrinology and metabolism.
[9] D. Dunger,et al. Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment. , 2004, The Journal of clinical endocrinology and metabolism.
[10] D. Guzick. Cardiovascular risk in PCOS. , 2004, The Journal of clinical endocrinology and metabolism.
[11] F. Orio,et al. The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. , 2004, The Journal of clinical endocrinology and metabolism.
[12] C. De Geyter,et al. Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome. , 2004, The Journal of clinical endocrinology and metabolism.
[13] Y. Sadovsky,et al. Insulin enhances the transcription of luteinizing hormone-β gene , 2004 .
[14] H. Zisser,et al. Screening for and Treatment of Polycystic Ovary Syndrome in Teenagers , 2004, Experimental biology and medicine.
[15] P. Claman. Men at risk: occupation and male infertility. , 2004, Fertility and sterility.
[16] M. McCarthy,et al. Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to Type 2 diabetes , 2004, Diabetologia.
[17] K. Taylor,et al. Androgen excess in women: experience with over 1000 consecutive patients. , 2004, The Journal of clinical endocrinology and metabolism.
[18] D. Schoenfeld,et al. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. , 2004, The Journal of clinical endocrinology and metabolism.
[19] Claude Lenfant,et al. Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Circulation.
[20] Claude Lenfant,et al. Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[21] Didier Dewailly,et al. Ultrasound assessment of the polycystic ovary: international consensus definitions. , 2003, Human reproduction update.
[22] M. Lawson,et al. Increased luteinizing hormone secretion in women with polycystic ovary syndrome is unaltered by prolonged insulin infusion. , 2003, The Journal of clinical endocrinology and metabolism.
[23] D. Petitti. Combination Estrogen–Progestin Oral Contraceptives , 2003 .
[24] G. Chrousos,et al. Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype. , 2004, The Journal of clinical endocrinology and metabolism.
[25] D. Ray,et al. Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency , 2003, Nature Genetics.
[26] W. Dietz,et al. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. , 2003, Archives of pediatrics & adolescent medicine.
[27] J. Taieb,et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. , 2003, Clinical chemistry.
[28] N. Goldenberg,et al. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. , 2003, Metabolism: clinical and experimental.
[29] Richard S Legro,et al. Polycystic ovary syndrome and cardiovascular disease: a premature association? , 2003, Endocrine reviews.
[30] M. Fassnacht,et al. Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome. , 2003, The Journal of clinical endocrinology and metabolism.
[31] S. Chew,et al. The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. , 2003, The Journal of clinical endocrinology and metabolism.
[32] N. Sattar,et al. Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome , 2003, The Lancet.
[33] R. Norman,et al. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. , 2003, The Cochrane database of systematic reviews.
[34] T. Kawashima,et al. Evidence for abnormal granulosa cell responsiveness to follicle-stimulating hormone in women with polycystic ovary syndrome. , 2003, The Journal of clinical endocrinology and metabolism.
[35] H. Mason,et al. Metformin has direct effects on human ovarian steroidogenesis. , 2003, Fertility and sterility.
[36] R. Colman,et al. Increased adiposity in female rhesus monkeys exposed to androgen excess during early gestation. , 2003, Obesity research.
[37] Jacqueline Akert. A new generation of contraceptives. , 2003, RN.
[38] J. Barrett,et al. Heritability of features of the insulin resistance syndrome in a community‐based study of healthy families , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[39] R. Legro,et al. Molecular progress in infertility: polycystic ovary syndrome. , 2002, Fertility and sterility.
[40] Samy I McFarlane,et al. Metformin: An Update , 2002, Annals of Internal Medicine.
[41] S. Franks,et al. Developmental origin of polycystic ovary syndrome - a hypothesis. , 2002, The Journal of endocrinology.
[42] P. Czernichow,et al. Endocrine consequences of premature pubarche in post‐pubertal Caucasian girls , 2002, Clinical endocrinology.
[43] B. Rich,et al. Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency. , 2002, The Journal of clinical endocrinology and metabolism.
[44] J. Fiet,et al. Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12‐month randomized trial , 2002, The British journal of dermatology.
[45] J. Wood,et al. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. , 2001, The Journal of clinical endocrinology and metabolism.
[46] C. Zouboulis,et al. The SAHA Syndrome , 2001, Hormone Research in Paediatrics.
[47] R. Rosenfield,et al. Polycystic ovary syndrome and insulin-resistant hyperinsulinemia. , 2001, Journal of the American Academy of Dermatology.
[48] J. Hall,et al. Polycystic ovarian syndrome--relationship to epilepsy and antiepileptic drug therapy. , 2001, The Journal of clinical endocrinology and metabolism.
[49] H. Escobar-Morreale,et al. Identification of the source of androgen excess in hyperandrogenic type 1 diabetic patients. , 2001, Diabetes care.
[50] W. Miller,et al. Thiazolidinediones but Not Metformin Directly Inhibit the Steroidogenic Enzymes P450c17 and 3β-Hydroxysteroid Dehydrogenase* , 2001, The Journal of Biological Chemistry.
[51] J. Vandenbroucke,et al. Oral contraceptives and the risk of venous thrombosis. , 2001, The New England journal of medicine.
[52] S. Weitsman,et al. Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. , 2001, The Journal of clinical endocrinology and metabolism.
[53] R. Cobin,et al. American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders. , 2001, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[54] C. Dierickx. Hair removal by lasers and intense pulsed light sources. , 2000, Seminars in cutaneous medicine and surgery.
[55] T. Arora,et al. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. , 2000, The Journal of clinical endocrinology and metabolism.
[56] M. Korbonits,et al. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome? , 2000, Clinical endocrinology.
[57] F. de Zegher,et al. Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide. , 2000, The Journal of clinical endocrinology and metabolism.
[58] R. Rosenfield,et al. Role of hormones in pilosebaceous unit development. , 2000, Endocrine reviews.
[59] P. G. Quinn,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Differential Activity of the Cytochrome P450 17�- Hydroxylase and Steroidogenic Acute Regulatory Protein Gene Promoters in Normal and Polycystic , 2022 .
[60] R. Rosenfield,et al. Hyperhidrosis as the only manifestation of hyperandrogenism in an adolescent girl. , 2000, Archives of dermatology.
[61] R. Voutilainen,et al. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids. , 2000, The Journal of clinical endocrinology and metabolism.
[62] A. Dunaif,et al. Selective insulin resistance in the polycystic ovary syndrome. , 1999, The Journal of clinical endocrinology and metabolism.
[63] J. J. Mukherjee,et al. Menstrual irregularity in women with acromegaly. , 1999, The Journal of clinical endocrinology and metabolism.
[64] F. de Zegher,et al. Anovulation after precocious pubarche: early markers and time course in adolescence. , 1999, The Journal of clinical endocrinology and metabolism.
[65] R. Rosenfield. Ovarian and adrenal function in polycystic ovary syndrome. , 1999, Endocrinology and metabolism clinics of North America.
[66] R. Legro,et al. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. , 1999, Molecular endocrinology.
[67] R. Norman,et al. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. , 1999, The Journal of clinical endocrinology and metabolism.
[68] D. Driscoll,et al. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[69] F. de Zegher,et al. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. , 1998, The Journal of clinical endocrinology and metabolism.
[70] P. Zimmet,et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[71] S. Witchel,et al. Variants of the type II 3beta-hydroxysteroid dehydrogenase gene in children with premature pubic hair and hyperandrogenic adolescents. , 1998, Molecular genetics and metabolism.
[72] C. Invitti,et al. Altered morning and nighttime pulsatile corticotropin and cortisol release in polycystic ovary syndrome. , 1998, Metabolism: clinical and experimental.
[73] J. Marshall,et al. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. , 1998, The Journal of clinical endocrinology and metabolism.
[74] P. A. Lee,et al. Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency. , 1997, Biochemical and molecular medicine.
[75] A. Dunaif,et al. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. , 1997, Endocrine reviews.
[76] R. Kofler,et al. CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11 beta-hydroxylase deficiency. , 1997, Human molecular genetics.
[77] S. Franks,et al. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome , 1997, Clinical endocrinology.
[78] D. Ehrmann. 7 Relation of functional ovarian hyperandrogenism to non-insulin dependent diabetes mellitus , 1997 .
[79] R. Rosenfield. 6 Current concepts of polycystic ovary syndrome , 1997 .
[80] P. Schwingl. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease , 1996, British journal of obstetrics and gynaecology.
[81] E. Porcu,et al. Longitudinal Change of Sonographic Ovarian Aspects and Endocrine Parameters in Irregular Cycles of Adolescence , 1995, Pediatric Research.
[82] W. Miller,et al. Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[83] R. Rosenfield. Are adrenal and ovarian function normal in true precocious puberty? , 1995, European Journal of Endocrinology.
[84] D. Apter,et al. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. , 1995, The Journal of clinical endocrinology and metabolism.
[85] S. Franks,et al. Polycystic ovary syndrome. , 1995, Archives of disease in childhood.
[86] D. Ehrmann,et al. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. , 1995, Endocrine reviews.
[87] Evaluation and treatment of hirsute women , 1995 .
[88] Ø. Lidegaard. Oral contraceptives, pregnancy and the risk of cerebra1 thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease , 1995, British journal of obstetrics and gynaecology.
[89] L. Levitsky,et al. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. , 1994, The Journal of clinical endocrinology and metabolism.
[90] S. Franks,et al. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. , 1994, The Journal of clinical endocrinology and metabolism.
[91] J. Little,et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. , 1994, Human molecular genetics.
[92] D. Apter,et al. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome. , 1994, The Journal of clinical endocrinology and metabolism.
[93] R. Azziz,et al. Clinical review 56: Nonclassic adrenal hyperplasia: current concepts. , 1994, The Journal of clinical endocrinology and metabolism.
[94] G. Huster,et al. Acne Vulgaris in Premenarchal Girls: An Early Sign of Puberty Associated With Rising Levels of Dehydroepiandrosterone , 1994 .
[95] S. Berga,et al. Increased luteinizing hormone and alpha-subunit secretion in women with hyperandrogenic anovulation. , 1993, The Journal of clinical endocrinology and metabolism.
[96] F. Keleştimur,et al. 17‐Hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome , 1993, Clinical endocrinology.
[97] L. Ibáñez,et al. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. , 1993, The Journal of clinical endocrinology and metabolism.
[98] S. O’Rahilly,et al. Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance. , 1993, The Journal of clinical endocrinology and metabolism.
[99] J. Nestler. Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance? , 1993, The Journal of clinical endocrinology and metabolism.
[100] S. Franks,et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. , 1992, Clinical endocrinology.
[101] D. Ehrmann,et al. Detection of functional ovarian hyperandrogenism in women with androgen excess. , 1992, The New England journal of medicine.
[102] R. Legro,et al. Polycystic ovary syndrome. , 1992, Current therapy in endocrinology and metabolism.
[103] D. Thompson,et al. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism. , 1990, The Journal of clinical endocrinology and metabolism.
[104] A. Dunaif,et al. Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome. , 1990, The Journal of clinical endocrinology and metabolism.
[105] W. Rosner,et al. The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. , 1990, Endocrine reviews.
[106] J. Wadsworth,et al. POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN , 1988, The Lancet.
[107] W. Futterweit,et al. Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. , 1986, The Journal of clinical endocrinology and metabolism.
[108] J. Price,et al. MULTIFOLLICULAR OVARIES: CLINICAL AND ENDOCRINE FEATURES AND RESPONSE TO PULSATILE GONADOTROPIN RELEASING HORMONE , 1985, The Lancet.
[109] R. Wild,et al. Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism. , 1983, American journal of obstetrics and gynecology.
[110] G. W. Moll,et al. Plasma free testosterone in the diagnosis of adolescent polycystic ovary syndrome. , 1983, The Journal of pediatrics.
[111] R. Bergenstal,et al. Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic women. , 1982, The Journal of clinical endocrinology and metabolism.
[112] M. Kim,et al. Hirsutism: implications, etiology, and management. , 1981, American journal of obstetrics and gynecology.
[113] G. W. Moll,et al. Testosterone binding and free plasma androgen concentrations under physiological conditons: chararacterization by flow dialysis technique. , 1979, The Journal of clinical endocrinology and metabolism.
[114] D. Krieger,et al. Pituitary tumors associated with hyperprolactinemia and polycystic ovarian disease. , 1979, Fertility and sterility.
[115] R. Rosenfield. Plasma free androgen patterns in hirsute women and their diagnostic implications. , 1979, The American journal of medicine.
[116] D. Apter,et al. Serum pregnenolone, progesterone, 17-hydroxyprogesterone, testosterone and 5 alpha-dihydrotestosterone during female puberty. , 1977, The Journal of clinical endocrinology and metabolism.
[117] R. Habershon. Letter: Kumidini hospital. , 1975, Lancet.
[118] R. Richart,et al. The prognosis for adolescents with menstrual abnormalities. , 1966, American journal of obstetrics and gynecology.
[119] Y. Sadovsky,et al. Insulin enhances the transcription of luteinizing hormone-beta gene. , 2004, American Journal of Obstetrics and Gynecology.
[120] B. Fauser,et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.
[121] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.
[122] D. Petitti. Clinical practice. Combination estrogen-progestin oral contraceptives. , 2003, The New England journal of medicine.
[123] R. Azziz,et al. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. , 2001, Fertility and sterility.
[124] D. Ehrmann,et al. Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism. , 2000, Journal of pediatric endocrinology & metabolism : JPEM.
[125] W. Dodson,et al. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. , 1999, The Journal of clinical endocrinology and metabolism.
[126] M. Cavaghan,et al. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. , 1999, Diabetes care.
[127] R. Clayton,et al. Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. , 1999, The Journal of clinical endocrinology and metabolism.
[128] G. Morgante,et al. Hormonal effects of flutamide in young women with polycystic ovary syndrome. , 1998, The Journal of clinical endocrinology and metabolism.
[129] D. Ehrmann. Relation of functional ovarian hyperandrogenism to non-insulin dependent diabetes mellitus. , 1997, Bailliere's clinical obstetrics and gynaecology.
[130] R. Rosenfield. Current concepts of polycystic ovary syndrome. , 1997, Bailliere's clinical obstetrics and gynaecology.
[131] K. Nonaka. [Idiopathic hirsutism]. , 1993, Ryoikibetsu shokogun shirizu.
[132] R. Pasquali,et al. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. , 1989, The Journal of clinical endocrinology and metabolism.
[133] G. Okoev,et al. [Diagnostic criteria for polycystic ovary syndrome]. , 1989, Akusherstvo i ginekologiia.
[134] A. Treloar,et al. Variation of the human menstrual cycle through reproductive life. , 1967, International journal of fertility.